Life Science Fest: June 3-4, 2008
home about entrepreneurs sponsors registration

Lead Sponsors

Morrison & Foerster


  Five Star Bank
City of Davis - Host City

A Radical Departure - New Media

Download a PDF
version of the agenda

 

Agenda - June 4 - Growth Strategies

Twenty Five Life Science Industry Experts Featured in Five Content-Packed Panels will enlighten you at this growth strategies summit with a keynote by Dr. Clare Pomeroy, Dean of the School of Medicine at UC Davis.

  • 8:00 - 9:00 AM  - Registration & Breakfast
  • Opening Remarks by Gopan Madathil, President, TechCoire & Chuck Farman, Morrison & Foerster, Co-Chair, LifeScienceFest 2008
  • 9:05 - 10:15 AM
    Investing in Healthcare Innovation: What VCs are looking for

    Leading investors share their insights on what gets their attention now, how to get them to open their wallet and their predictions for new innovations, valuations, mergers & acquisitions and more. Panelists include:

    Ilan Zipkin, Prospect Venture Partners
    Lisa Suennen, Psilos Ventures
    Mike Perry, Bay City Capital
    Paul Grand, RCT Bioventures
    Maik Klasen, Frost & Sullivan (Moderator)

  • 10:30 -11:30 AM
    Do's and Don'ts in starting a life science business

    Leading industry executives share their perspective on what they think are the best practices, success factors and things you must consider in building your life sciences business - whether or not you are seeking funding. Panelists include :
     
    Dinesh Patel, CEO, Arete Therapeutics
    Steve Fry, Biomedical Innovations
    Nick Mourlas, Acumen Medical
    Grant Campany, Senior Vice President, Zoomedia

  • 11:30 AM - 12:00 PM - Keynote by Dr. Claire Pomeroy
    Dean, School of Medicine, UC Davis and Vice Chancellor, Human Health Sciences

  • 12:00 - 1:30 PM - Lunch Break

  • 1:30 - 2:30 PM
    Preparing Your Company for IP Due Diligence

    Life Science companies face increasing scrutiny with respect to the strength of their patent portfolios and their freedom to operate as they seek early stage funding and successful exits. This panel will discuss key issues in IP due diligence from the perspective of both early stage investors and big pharma including licensing issues, scope of patent protection and infringement issues.  Once problems are identified, how do you solve them in order for your company to move forward? The expert panel include:

    Mark Seka, Novartis
    Dr. Phil Reilly, Macusight
    Paul Jahn, Morrison & Foerster
    Matt Kreeger, Morrison & Foerster
    Mike Ward, Morrision & Foerster will moderate the panel

  • 2:30 - 3:30 PM
    Driving Revenue through strategic relationships & partnerships
    All life science startups are faced with the challenge of raising capital and growing their business.  Join a team of industry experts who will discuss how strategic partnering can provide access to valuable resources and expertise, impact your value to investors, and catalyze your corporate development.  Featured executives include:

    William Goure, Acumen Pharmaceuticals
    George Miljanich, Airmid
    Mohan Iyer, Burrill & Co
    Gulzar Sandhu, Bayer Healthcare
    Josh Shinoff, Applied Biosystems
    Adam Bristol, Biotechnology Value Fund will moderate the panel

  • 3:30 - 3:45 - Coffee Break

  • 3:45 - 5:00 PM
    Exploring Exit strategies for your life science business
    Join a panel of experts from companies that have had successful exits in the last 12-18 months as they share their insights and strategies on the key M&A/IPO trends affecting private companies and their investors and what steps the Board and senior management can take to increase the likelihood of a successful exit. Panelists include:

    Emory Anderson, Adeza Biomedical
    Frank Ruderman, Berkeley Heart Lab
    James Stewart, VIA Pharmaceuticals
    Peng Leong, Piper Jaffray
    John Campbell Morrison & Foerster

  • 5:00 PM - Closing remarks and adjourn to reception

Register Now to attend the full conference or just the Venture Summit or Growth Strategies Summit